Global Point-of-Care or Rapid Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Point-of-Care or Rapid Testing market report explains the definition, types, applications, major countries, and major players of the Point-of-Care or Rapid Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Bio-Rad Laboratories

    • Danaher

    • Helena Laboratories

    • Yuwell

    • DAAN GENE

    • ARKRAY

    • Ascensia

    • Wuhan EasyDiagnosis Biomedicine

    • OraSure Technologies

    • Abbott

    • Trividia Health

    • Runbio

    • KHB

    • A Menarini Diagnostics

    • Siemens Healthcare

    • Johnson & Johnson

    • BioMerieux

    • Phamatech

    • Nova Biomedical

    • Sinocare

    • Accriva

    • Roche

    • Chembio Diagnostics

    • Wondfo

    • Abaxis (Zoetis)

    • Quidel

    • Ortho Clinical Diagnostics

    By Type:

    • Blood Glucose Testing

    • Infectious Diseases Testing

    • Cardiac Markers Testing

    • Coagulation Testing

    • Pregnancy and Fertility Testing

    • Blood Gas/Electrolytes Testing

    • Urinalysis Testing

    • Others

    By End-User:

    • Clinics

    • Hospitals

    • Laboratory

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Point-of-Care or Rapid Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Point-of-Care or Rapid Testing Outlook to 2028- Original Forecasts

    • 2.2 Point-of-Care or Rapid Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Point-of-Care or Rapid Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Point-of-Care or Rapid Testing Market- Recent Developments

    • 6.1 Point-of-Care or Rapid Testing Market News and Developments

    • 6.2 Point-of-Care or Rapid Testing Market Deals Landscape

    7 Point-of-Care or Rapid Testing Raw Materials and Cost Structure Analysis

    • 7.1 Point-of-Care or Rapid Testing Key Raw Materials

    • 7.2 Point-of-Care or Rapid Testing Price Trend of Key Raw Materials

    • 7.3 Point-of-Care or Rapid Testing Key Suppliers of Raw Materials

    • 7.4 Point-of-Care or Rapid Testing Market Concentration Rate of Raw Materials

    • 7.5 Point-of-Care or Rapid Testing Cost Structure Analysis

      • 7.5.1 Point-of-Care or Rapid Testing Raw Materials Analysis

      • 7.5.2 Point-of-Care or Rapid Testing Labor Cost Analysis

      • 7.5.3 Point-of-Care or Rapid Testing Manufacturing Expenses Analysis

    8 Global Point-of-Care or Rapid Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Point-of-Care or Rapid Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Point-of-Care or Rapid Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Point-of-Care or Rapid Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Point-of-Care or Rapid Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Glucose Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Infectious Diseases Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cardiac Markers Testing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Coagulation Testing Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Pregnancy and Fertility Testing Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Blood Gas/Electrolytes Testing Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Urinalysis Testing Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Point-of-Care or Rapid Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Laboratory Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Point-of-Care or Rapid Testing Market Analysis and Outlook till 2022

    • 10.1 Global Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.2.2 Canada Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.2.3 Mexico Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.2 UK Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.3 Spain Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.4 Belgium Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.5 France Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.6 Italy Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.7 Denmark Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.8 Finland Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.9 Norway Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.10 Sweden Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.11 Poland Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.12 Russia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.3.13 Turkey Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.2 Japan Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.3 India Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.4 South Korea Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.5 Pakistan Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.7 Indonesia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.8 Thailand Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.9 Singapore Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.10 Malaysia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.11 Philippines Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.4.12 Vietnam Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.2 Colombia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.3 Chile Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.4 Argentina Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.5 Venezuela Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.6 Peru Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.5.8 Ecuador Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.6.2 Kuwait Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.6.3 Oman Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.6.4 Qatar Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.7.2 South Africa Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.7.3 Egypt Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.7.4 Algeria Point-of-Care or Rapid Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Point-of-Care or Rapid Testing Consumption (2017-2022)

      • 10.8.2 New Zealand Point-of-Care or Rapid Testing Consumption (2017-2022)

    11 Global Point-of-Care or Rapid Testing Competitive Analysis

    • 11.1 Bio-Rad Laboratories

      • 11.1.1 Bio-Rad Laboratories Company Details

      • 11.1.2 Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Bio-Rad Laboratories Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.1.4 Bio-Rad Laboratories Point-of-Care or Rapid Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Danaher

      • 11.2.1 Danaher Company Details

      • 11.2.2 Danaher Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Danaher Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.2.4 Danaher Point-of-Care or Rapid Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Helena Laboratories

      • 11.3.1 Helena Laboratories Company Details

      • 11.3.2 Helena Laboratories Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Helena Laboratories Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.3.4 Helena Laboratories Point-of-Care or Rapid Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Yuwell

      • 11.4.1 Yuwell Company Details

      • 11.4.2 Yuwell Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Yuwell Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.4.4 Yuwell Point-of-Care or Rapid Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 DAAN GENE

      • 11.5.1 DAAN GENE Company Details

      • 11.5.2 DAAN GENE Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 DAAN GENE Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.5.4 DAAN GENE Point-of-Care or Rapid Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 ARKRAY

      • 11.6.1 ARKRAY Company Details

      • 11.6.2 ARKRAY Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 ARKRAY Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.6.4 ARKRAY Point-of-Care or Rapid Testing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Ascensia

      • 11.7.1 Ascensia Company Details

      • 11.7.2 Ascensia Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Ascensia Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.7.4 Ascensia Point-of-Care or Rapid Testing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Wuhan EasyDiagnosis Biomedicine

      • 11.8.1 Wuhan EasyDiagnosis Biomedicine Company Details

      • 11.8.2 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.8.4 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 OraSure Technologies

      • 11.9.1 OraSure Technologies Company Details

      • 11.9.2 OraSure Technologies Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 OraSure Technologies Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.9.4 OraSure Technologies Point-of-Care or Rapid Testing Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Abbott

      • 11.10.1 Abbott Company Details

      • 11.10.2 Abbott Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Abbott Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.10.4 Abbott Point-of-Care or Rapid Testing Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Trividia Health

      • 11.11.1 Trividia Health Company Details

      • 11.11.2 Trividia Health Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Trividia Health Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.11.4 Trividia Health Point-of-Care or Rapid Testing Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Runbio

      • 11.12.1 Runbio Company Details

      • 11.12.2 Runbio Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Runbio Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.12.4 Runbio Point-of-Care or Rapid Testing Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 KHB

      • 11.13.1 KHB Company Details

      • 11.13.2 KHB Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 KHB Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.13.4 KHB Point-of-Care or Rapid Testing Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 A Menarini Diagnostics

      • 11.14.1 A Menarini Diagnostics Company Details

      • 11.14.2 A Menarini Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 A Menarini Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.14.4 A Menarini Diagnostics Point-of-Care or Rapid Testing Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Siemens Healthcare

      • 11.15.1 Siemens Healthcare Company Details

      • 11.15.2 Siemens Healthcare Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Siemens Healthcare Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.15.4 Siemens Healthcare Point-of-Care or Rapid Testing Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Johnson & Johnson

      • 11.16.1 Johnson & Johnson Company Details

      • 11.16.2 Johnson & Johnson Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Johnson & Johnson Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.16.4 Johnson & Johnson Point-of-Care or Rapid Testing Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 BioMerieux

      • 11.17.1 BioMerieux Company Details

      • 11.17.2 BioMerieux Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 BioMerieux Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.17.4 BioMerieux Point-of-Care or Rapid Testing Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Phamatech

      • 11.18.1 Phamatech Company Details

      • 11.18.2 Phamatech Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Phamatech Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.18.4 Phamatech Point-of-Care or Rapid Testing Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Nova Biomedical

      • 11.19.1 Nova Biomedical Company Details

      • 11.19.2 Nova Biomedical Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Nova Biomedical Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.19.4 Nova Biomedical Point-of-Care or Rapid Testing Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Sinocare

      • 11.20.1 Sinocare Company Details

      • 11.20.2 Sinocare Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Sinocare Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.20.4 Sinocare Point-of-Care or Rapid Testing Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Accriva

      • 11.21.1 Accriva Company Details

      • 11.21.2 Accriva Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Accriva Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.21.4 Accriva Point-of-Care or Rapid Testing Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Roche

      • 11.22.1 Roche Company Details

      • 11.22.2 Roche Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Roche Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.22.4 Roche Point-of-Care or Rapid Testing Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    • 11.23 Chembio Diagnostics

      • 11.23.1 Chembio Diagnostics Company Details

      • 11.23.2 Chembio Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.23.3 Chembio Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.23.4 Chembio Diagnostics Point-of-Care or Rapid Testing Product Portfolio

      • 11.23.5 Recent Research and Development Strategies

    • 11.24 Wondfo

      • 11.24.1 Wondfo Company Details

      • 11.24.2 Wondfo Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.24.3 Wondfo Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.24.4 Wondfo Point-of-Care or Rapid Testing Product Portfolio

      • 11.24.5 Recent Research and Development Strategies

    • 11.25 Abaxis (Zoetis)

      • 11.25.1 Abaxis (Zoetis) Company Details

      • 11.25.2 Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.25.3 Abaxis (Zoetis) Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.25.4 Abaxis (Zoetis) Point-of-Care or Rapid Testing Product Portfolio

      • 11.25.5 Recent Research and Development Strategies

    • 11.26 Quidel

      • 11.26.1 Quidel Company Details

      • 11.26.2 Quidel Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.26.3 Quidel Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.26.4 Quidel Point-of-Care or Rapid Testing Product Portfolio

      • 11.26.5 Recent Research and Development Strategies

    • 11.27 Ortho Clinical Diagnostics

      • 11.27.1 Ortho Clinical Diagnostics Company Details

      • 11.27.2 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.27.3 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

      • 11.27.4 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product Portfolio

      • 11.27.5 Recent Research and Development Strategies

    12 Global Point-of-Care or Rapid Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Blood Glucose Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Infectious Diseases Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Cardiac Markers Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Coagulation Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Pregnancy and Fertility Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Blood Gas/Electrolytes Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Urinalysis Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Point-of-Care or Rapid Testing Market Analysis and Outlook to 2028

    • 13.1 Global Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.5 France Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.3 India Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Point-of-Care or Rapid Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Point-of-Care or Rapid Testing

    • Figure of Point-of-Care or Rapid Testing Picture

    • Table Global Point-of-Care or Rapid Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Point-of-Care or Rapid Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Blood Glucose Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiac Markers Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Coagulation Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Pregnancy and Fertility Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Gas/Electrolytes Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Urinalysis Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratory Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Table North America Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure United States Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure Germany Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure UK Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure France Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table APAC Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure China Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure India Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table South America Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure Brazil Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table GCC Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure Bahrain Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table Africa Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure Nigeria Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania Point-of-Care or Rapid Testing Consumption by Country (2017-2022)

    • Figure Australia Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Point-of-Care or Rapid Testing Consumption and Growth Rate (2017-2022)

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Bio-Rad Laboratories Point-of-Care or Rapid Testing Product Portfolio

    • Table Danaher Company Details

    • Table Danaher Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Danaher Point-of-Care or Rapid Testing Product Portfolio

    • Table Helena Laboratories Company Details

    • Table Helena Laboratories Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helena Laboratories Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Helena Laboratories Point-of-Care or Rapid Testing Product Portfolio

    • Table Yuwell Company Details

    • Table Yuwell Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuwell Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Yuwell Point-of-Care or Rapid Testing Product Portfolio

    • Table DAAN GENE Company Details

    • Table DAAN GENE Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table DAAN GENE Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table DAAN GENE Point-of-Care or Rapid Testing Product Portfolio

    • Table ARKRAY Company Details

    • Table ARKRAY Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARKRAY Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table ARKRAY Point-of-Care or Rapid Testing Product Portfolio

    • Table Ascensia Company Details

    • Table Ascensia Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ascensia Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Ascensia Point-of-Care or Rapid Testing Product Portfolio

    • Table Wuhan EasyDiagnosis Biomedicine Company Details

    • Table Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product Portfolio

    • Table OraSure Technologies Company Details

    • Table OraSure Technologies Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table OraSure Technologies Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table OraSure Technologies Point-of-Care or Rapid Testing Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Abbott Point-of-Care or Rapid Testing Product Portfolio

    • Table Trividia Health Company Details

    • Table Trividia Health Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trividia Health Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Trividia Health Point-of-Care or Rapid Testing Product Portfolio

    • Table Runbio Company Details

    • Table Runbio Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Runbio Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Runbio Point-of-Care or Rapid Testing Product Portfolio

    • Table KHB Company Details

    • Table KHB Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table KHB Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table KHB Point-of-Care or Rapid Testing Product Portfolio

    • Table A Menarini Diagnostics Company Details

    • Table A Menarini Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table A Menarini Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table A Menarini Diagnostics Point-of-Care or Rapid Testing Product Portfolio

    • Table Siemens Healthcare Company Details

    • Table Siemens Healthcare Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Siemens Healthcare Point-of-Care or Rapid Testing Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Johnson & Johnson Point-of-Care or Rapid Testing Product Portfolio

    • Table BioMerieux Company Details

    • Table BioMerieux Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table BioMerieux Point-of-Care or Rapid Testing Product Portfolio

    • Table Phamatech Company Details

    • Table Phamatech Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phamatech Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Phamatech Point-of-Care or Rapid Testing Product Portfolio

    • Table Nova Biomedical Company Details

    • Table Nova Biomedical Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nova Biomedical Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Nova Biomedical Point-of-Care or Rapid Testing Product Portfolio

    • Table Sinocare Company Details

    • Table Sinocare Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinocare Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Sinocare Point-of-Care or Rapid Testing Product Portfolio

    • Table Accriva Company Details

    • Table Accriva Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accriva Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Accriva Point-of-Care or Rapid Testing Product Portfolio

    • Table Roche Company Details

    • Table Roche Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Roche Point-of-Care or Rapid Testing Product Portfolio

    • Table Chembio Diagnostics Company Details

    • Table Chembio Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chembio Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Chembio Diagnostics Point-of-Care or Rapid Testing Product Portfolio

    • Table Wondfo Company Details

    • Table Wondfo Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wondfo Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Wondfo Point-of-Care or Rapid Testing Product Portfolio

    • Table Abaxis (Zoetis) Company Details

    • Table Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abaxis (Zoetis) Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Abaxis (Zoetis) Point-of-Care or Rapid Testing Product Portfolio

    • Table Quidel Company Details

    • Table Quidel Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quidel Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Quidel Point-of-Care or Rapid Testing Product Portfolio

    • Table Ortho Clinical Diagnostics Company Details

    • Table Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Main Business and Markets Served

    • Table Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product Portfolio

    • Figure Global Blood Glucose Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiac Markers Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coagulation Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pregnancy and Fertility Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Gas/Electrolytes Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinalysis Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Table North America Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure China Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Point-of-Care or Rapid Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Point-of-Care or Rapid Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.